Interleukins in Acute Pancreatitis

References

• Rinderknecht H. Fatal pancreatitis a consequence of excessive leukocyte stimulation. Intern J Pankreatol 1988; 3: 105–12
   PubMedGoogle Scholar
• Andus T, Palitzsch K-D, Gross V, Schölmerich J. Metabolische Funktionen der Zytokine. Dtsch Med Wschr 1993; 118: 306–13
   Google Scholar
• Schölmerich J, Schümichen C, Lausen M. Scintigraphic assessment of leukocyte infiltration in acute pancreatitis using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Dig Dis Sci 1991; 36: 65–70
   PubMedGoogle Scholar
• Groβ V, Schölmerich J, Leser H-G. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins, C-reactive protein, α1-antitrypsin and protease inhibitor α2-macroglobulin. Dig Dis Sci 1990; 35: 97–105
   Google Scholar
• Bitchier M, Malfertheiner P, Schoetensack C, Uhl W, Scherbaum W, Beger H-G. Wertigkeit biochemischer und bildgebender Verfahren für Diagnose und Prognose der akuten Pankreatitis. Z Gastroenterol 1986; 24: 100–9
   Google Scholar
• Leser H-G, Gross V, Scheibenbogen C. Elevation of interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101: 782–5
   PubMed Web of Science ®Google Scholar
• Viedma J A, Pérez-Mateo M, Dominguez J E, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264–7
   PubMedGoogle Scholar
• Curley P J, McMahon M J, Lancaster F. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin interleukin 6 and disease severity. Br J Surg 1993; 80: 1312–5
   PubMedGoogle Scholar
• Exley A R, Leese T, Holliday M P, Swann R A, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992; 33: 1126–8
   PubMed Web of Science ®Google Scholar
• McKay G, Gallagher G, Imrie C W, Baxter J N. Monocyte tumour necrosis factor alpha production in acute pancreatitis is related to outcome. Gut 1993; 34: 28
   Google Scholar
• Grewal H P, Koth M, El Din A M. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115: 213–21
   PubMed Web of Science ®Google Scholar
• Sameshima H, Satoshi I, Katsutaka M. The role of tumor necrosis factor-alpha in the aggravation of cerulein-induced pancreatitis in rats. Int J Pancreatol 1993; 14: 107–15
   PubMedGoogle Scholar
• Fink G, Franz M, Norman J. Systemic inflammatory cytokines induced by acute pancreatitis originate within the pancreas (Abstract). Gastroenterology 1995; 108: A818
   Google Scholar
• Groβ V, Leser H-G, Andreesen R. Interleukin-8 (IL-8) and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1991; 22: 200–3
   Google Scholar
• Heinisch A, Ballé C, Kadow R. New aspects in monitoring and therapy in severe acute pancreatitis: anticytokines and plasmapheresis (Abstract). Gut 1995; 37: A101
   Google Scholar
• Vogt W, Messmann H, Heinisch A. Does ERP induce an acute phase response? Serum concentrations of enzymes, leukocytes, IL-6 and CRP after ERP (Abstract). Int J Pancreatol 1994; 16: 323
   Google Scholar
• Pezzilli R, Billi P, Gullo L. Behavior of serum soluble interleukin-2 receptor soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 1994; 55: 268–73
   PubMed Web of Science ®Google Scholar
• Widdison A L, May R E. Circulating lymphocytes early in acute pancreatits (Abstract). Gastroenterology 1995; 108: A401
   Google Scholar
• Friess H, Büehler M E, Hofbauer B, Uhl W, Gold L I, Kore M. Overexpression of transforming growth factor βs and their receptors in acute pancreatitis in humans (Abstract). Gastroenterology 1995; 108: A354
   Google Scholar
• Uhl W, Büchler M, Malfertheiner P, Martini M, Beger H G. PMN-elastase in comparison with CRP antiproteases and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253–9
   PubMed Web of Science ®Google Scholar
• Schölmerich J, Heinisch A, Leser H-G. Diagnostic approach to acute pancreatitis: diagnosis assessment of etiology and prognosis. Hepato-gastroenterol 1993; 40: 531–7
   PubMedGoogle Scholar
• Derkx B, Taminian J, Radema S. Tumor-necrosis-factor antibody treatment in Crohn's disease (Letter). Lancet 1993; 342: 173–4
   PubMed Web of Science ®Google Scholar
• Grewal H P, Mohey-el-Din A, Gaber L, Loth M, Gaber A O. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994; 167: 214–18
   PubMed Web of Science ®Google Scholar
• Grewal H P, Hughes C B, Mohey El-din A B, Gaber L W, Gaber A O. Anti-TNF therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Digestive Diseases Week, New Orleans 1994
   Google Scholar
• Guice K S, Oldham K T, Remick D G, Kunkel S L, Ward P A. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res 1991; 51: 495–9
   Google Scholar
• Echternacher B, Falk W, Maennel D N, Krammer P H. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145: 3762–6
   Google Scholar
• Norman J, Franz M, Messina J. Interleukin-1-receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995; 117: 648–55
   PubMed Web of Science ®Google Scholar
• Van Laethem J L, Marchant A, Delvaux A. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917–22
   PubMed Web of Science ®Google Scholar